Introduction {#S1}
============

With the increasing emergence of antibacterial resistance (ABR) among common pathogens, the quest to discover novel and new antibiotics is, therefore, urgent. ABR is the natural ability of bacteria to resist the effects of antibiotics, thereby rendering antibiotics less effective ([@B51]; [@B83]). Various resistance mechanisms such as enzyme mutations, multidrug efflux-mediated resistance, production of antibiotic degrading enzymes, and modification of drug binding sites were developed by bacteria as their defense against antibiotics ([@B73]; [@B83]). These resistance mechanisms are developed rapidly, and the spread of multidrug-resistant strains is uncontrollable. Unfortunately, the ABR crisis is coupled with shortage of new antibiotics to replace those rendered ineffective by ABR strains. Therefore, urgent efforts to discover new antibiotics from underexplored sources are needed.

Members of the genus *Streptomyces* of the phylum Actinobacteria are soil saprophytes that are known producers of antibiotics ([@B69]; [@B87]; [@B50]; [@B88]). These microorganisms contain high GC content in their DNA sequences and are reported to have antibiotic-producing biosynthetic gene clusters (BGC) ([@B40]; [@B26]; [@B66]) that produces about 75% of the clinically available antibacterial drugs in the market ([@B50]). However, in the last 20 years, the re-discovery of previously characterized bioactive compounds and strain redundancy decreased the interest in these soil-dwelling bacteria as a source of novel bioactive compounds ([@B87]; [@B3]). Thus, *Streptomyces* living in other niches, such as the marine environment, gained value because of their chemodiversity ([@B18]; [@B26]; [@B87]; [@B50]; [@B66]; [@B2]; [@B3]).

In response to the ABR crisis and the challenges of finding new antibiotics, we collected marine sediments near Romblon, Philippines as a source of marine-derived Actinobacteria. We focused on isolating the Actinobacteria from marine sediments and screen their crude extracts against *Staphylococcus aureus* ATCC BAA-44, profiling antibacterial activity and determining their membrane disruption ability, and identifying the compound(s) responsible for antibiotic activity. We performed a culture-dependent isolation approach using the dry stamp and heat shock methods ([@B56]; [@B44]; [@B24]) utilizing minimal marine media to isolate marine sediment-derived Actinobacteria. We isolated 35 actinobacterial isolates with six isolates (17% hit rate) active against *S. aureus* ATCC BAA-44. *Streptomyces griseorubens* strain DSD069 showed the highest antibiotic activity. Its crude extract caused cell membrane damage and intracellular leakage, leading to compromised cell membrane integrity and death of *S. aureus* ATCC BAA-44. The antibiotic compounds were accumulated in the growth medium during fermentation, which were later identified as shunt metabolites in the biosynthesis of anticancer anthracycline derivatives such as doxorubicin, daunorubicin, and cinerubins. This work is the first report on the accumulation of anticancer anthracycline derivatives shunt metabolites by Philippine marine sediment-derived *Streptomyces* strain without genetic modification. Thus, our study provides evidence that natural bacterial strain can produce Bisanhydroaklavinone and 1-Hydroxybisanhydroaklavinone as antibiotic leads to combat ABR.

Materials and Methods {#S2}
=====================

Sample Collection and Culture-Dependent Isolation of Marine Actinobacteria {#S2.SS1}
--------------------------------------------------------------------------

Sediment samples were collected from six sites near Alad and Lugbong islands of Romblon, Philippines. The sediments were collected 200--500 m away from the islands by SCUBA at a depth of 20--30 m. The sediment samples were placed in sterile cylindrical tubes and kept at 4°C until further processing. Dry stamp method (DSM) and heat shock method (HSM) ([@B56]; [@B44]; [@B24]) using selective minimal marine media (ISP4 and noble agar) ([@B24]) were used to grow the marine sediment-derived Actinobacteria. The inoculated plates were incubated at room temperature for 30 to 60 days.

Morphological Characterization of Marine Sediment-Derived Actinobacteria {#S2.SS2}
------------------------------------------------------------------------

Marine sediment-derived Actinobacteria were examined morphologically in terms of their mycelium production, specifically substratum mycelium (pigmentation) and aerial mycelium (spores). Spore size was measured using scanning electron microscopy (SEM). The spores were washed twice with PBS (0.1 M, pH 7.4), centrifuged, and fixed with glutaraldehyde solution (2.5% in PBS) for 1.5 h at 4°C. The fixed spores were dehydrated using gradient concentration of ethanol (30, 50, 85, 95, 100%) and twice with *t*-butyl alcohol before freezing at −20°C for 5 min. The spores were viewed under a scanning electron microscope, SEM (JEOL JSM 5510LV) ([@B34]).

Extraction of Secondary Metabolites {#S2.SS3}
-----------------------------------

Actinobacterial isolates were grown in marine medium 1 (MM1) agar ([@B24]) plates. Successive re-plating was done to obtain a pure isolate. Large-scale fermentation of the isolates was performed according to the method of [@B24]. Secondary metabolites were extracted using EtOAc and the extract partitioned with water. The EtOAc fractions were concentrated *in vacuo* and subsequently stored at −80°C until further use.

Multidrug-Resistant *Staphylococcus aureus* ATCC BAA-44 {#S2.SS4}
-------------------------------------------------------

*Staphylococcus aureus* ATCC BAA-44 is a particular strain containing the SCC*mec* Type I gene. It is resistant to 18 clinically significant antibiotics namely ampicillin, amoxicillin/clavulanic acid, ciprofloxacin, cephalothin, doxycycline, gentamicin, erythromycin, imipenem, methicillin, penicillin, tetracycline, oxacillin, azithromycin, clindamycin, ceftriaxone, rifampin, amikacin, and tobramycin \[[@B74]\].

Antibacterial Activity Assay {#S2.SS5}
----------------------------

### Agar Well Diffusion Assay {#S2.SS5.SSS1}

The preliminary screening of extracts against *S. aureus* ATCC BAA-44 was performed using agar well diffusion assay. The *S. aureus* ATCC BAA-44 (1 × 10^6^ CFU/mL) in agar medium was prepared by pour plate technique. Thereafter, three wells were punched on the agar. The first well was filled with tetracycline (0.050 mg/well) as a positive control. The second well was filled with DMSO as a negative control, and the third well was filled with Actinobacteria crude extracts (2.0 mg/well). The samples were allowed to diffuse unto the agar for 1 h before incubation at 37°C for 18--24 h. Zone of inhibition was measured in mm after the incubation period. Extracts that exhibited zone of inhibition of more than 4.0 mm were considered to have antibacterial activity ([@B13]; [@B81]).

### Microbroth Susceptibility Assay {#S2.SS5.SSS2}

The *S. aureus* ATCC BAA-44 (1 × 10^6^ CFU/mL) in Mueller-Hinton broth (MHB) was prepared in a 96-well plate and exposed to different treatments \[tetracycline 0.25 mg/mL in DMSO (positive control), DMSO (negative control), and crude extracts (2.5 mg/mL of DMSO)\] for 18--24 h at 37°C. The bacterial density at OD 620 nm was measured after incubation using a microplate reader (Multiskan^TM^ FC Thermo Fisher) and percent growth inhibitions were calculated.

Extracts with more than 50% growth inhibition were confirmed for antibacterial activity. The extract with the highest % growth inhibition against the multidrug-resistant *S. aureus* ATCC BAA-44 was further subjected to antibacterial activity profiling, mechanism of action assay, and chemical profiling for antibiotic compound identification ([@B54]; [@B25]; [@B24]; [@B39]).

16S rRNA Gene Amplification and Sequencing {#S2.SS6}
------------------------------------------

Actinobacterial DNA was extracted using the DNeasy Blood and Tissue Kit (Qiagen) according to the manufacturer's instruction. For 16S rRNA Gene amplification, universal primers 27F (5′-AGAGTTTGATCCTGGCTCAG-3′) and 1492R (5′-TACGGCTACCTTGTTACGACTT′) were used in PCR reaction. The reaction mixture (50 μL) contained 5 μL Taq Polymerase (5 units/μL), 5 μL MgCl~2~ (50 mM), 5 μL Taq Buffer, 5 μL dNTPs (10 mM), 3 μL 27F primer (10 mM), 3 μL 1492R primer (10 mM), 19 μL nuclease-free H~2~O (ultrapure water) and 100 ng/μL DNA template. The PCR conditions were as follows: initial denaturation at 98°C for 3 min; 35 cycles at 98°C for 10 s, 60°C for 10 s and 72°C for 60 s; and a 10-min final extension at 72°C (T100^TM^ BioRad Thermal Cycler). The amplified products were cleaned using the QIAquick PCR cleanup kit (Qiagen) according to the manufacturer's protocol. The universal primers 27F, 518F, 800R, and 1492R were used to obtain the 1300--1500 bp gene sequences. The species-level affiliation of the sequenced 16S rRNA gene was determined using BLAST ([@B4]). The phylogenetic tree was constructed using multiple alignments with maximum likelihood method in Mega 7.0 software ([@B53]). Bootstrap analysis based on 1,000 replicates evaluated the resulting tree topologies.

Antibacterial Activity Profiling {#S2.SS7}
--------------------------------

### Time-Kill Kinetics Assay {#S2.SS7.SSS1}

Following the same procedure in microbroth susceptibility, the assay was performed using 0.25 mg/mL tetracycline (positive control), DMSO (negative control), and 2.5 mg/mL of most active extract as treatments. In this assay, measurement of bacterial densities was obtained every 6 h (0, 6, 12, 18, and 24 h) within a 24 h period using microplate reader (Multiskan^TM^ FC Thermo Fisher). Percent bacterial growth inhibition of the treatments at different time points was calculated and plotted ([@B76]; [@B62]).

### Minimum Inhibitory Concentration (MIC) {#S2.SS7.SSS2}

Two-fold serially diluted concentrations of extract (dilution range of 625 -- 0.61 μg/mL) and tetracycline (dilution range of 62.5 -- 0.061 μg/mL) was utilized, with DMSO as the negative control. The test bacterial strain (1 × 10^6^ CFU/mL) was exposed to different treatments in a 96-well plate for 18--24 h at 37°C. The bacterial densities of different concentrations were measured at OD 620 nm using microplate reader (Multiskan^TM^ FC Thermo Fisher). The corresponding % growth inhibition was calculated to identify the minimum concentration that could inhibit 90% of bacterial growth ([@B28]; [@B5]; [@B25]).

Although tetracycline was listed as one of the antibiotics with resistance against *S. aureus* ATCC BAA-44, this antibiotic was used as the positive control in all the antibacterial assays covered in this work. We found that *S. aureus* ATCC BAA-44 has an MIC value of 31.25--50 μg/mL for tetracycline according to the protocol described in this work. Tetracycline susceptibility to *S. aureus* ATCC BAA-44 was also observed by other groups where MIC values were reported at 16 μg/mL ([@B65]) and 64 μg/mL ([@B63]).

### Membrane Leakage Assay {#S2.SS7.SSS3}

Overnight grown broth culture of *S. aureus* ATCC BAA-44 (0.2 OD 620 nm) was prepared. Subsequently, the bacterial inoculum was exposed for 18--24 h to different treatments, namely 5% Tween 80 (positive control), DMSO (negative control), and the most active extract with concentrations of 2.50, 1.25, and 0.625 mg/mL in DMSO. The measurement of proteins and DNA that leaked out of the cell membrane was measured using a UV-Vis spectrophotometer (Shimadzu UV1280 Spectrophotometer) ([@B77]; [@B78]). Leaked DNA was measured at 260 nm according to the method of [@B91], and proteins were measured by modifying the procedures of [@B12]. Here, proteins were directly measured at 280 nm instead of colorimetric measurement.

### Transmission Electron Microscopy (TEM) {#S2.SS7.SSS4}

Bacterial cells of *S. aureus* ATCC BAA-44 (0.6 OD 620 nm) were exposed to the extract at 2.5 mg/mL concentration and DMSO (negative control) for 24 h incubation period. Untreated bacterial cells were also prepared as a control. The extract-treated, DMSO-treated, and untreated cells were then processed to adhere to an aluminum film and then washed thrice with phosphate buffer saline (PBS) with a concentration of 0.1 M (pH 7.4). After washing, the cells were stained with 2% phosphotungstic acid and subjected to dehydration with a gradient concentration of ethanol (30, 50, 85, 95, 100%). The dehydrated cells were washed twice with *t*-butyl alcohol before freezing it at −20°C for 5 min. The cells were then placed in the TEM sample holder and coated with gold using a sputter. The cells were viewed using TEM (JEOL JEM 1010) ([@B68]; [@B49]; [@B8]).

### Flow Cytometry {#S2.SS7.SSS5}

Overnight broth culture of *S. aureus* ATCC BAA-44 was utilized. The cells were harvested by centrifugation (4500 rpm for 5 min) and re-suspended in PBS (7.4 pH) to a final bacterial density of 0.05 OD 600 nm. The bacterial suspension in PBS was transferred to a 96-well plate. The bacterial suspensions were treated with vancomycin (7.5 mg/mL), DMSO, and active extract (2.5 mg/mL). Untreated cells (only bacterial suspension, negative control) and 70% ethanol-treated cells as positive control to represent dead cells were transferred onto their corresponding wells in 96-well plate. The plate was incubated for 4 h at 37°C. After incubation, the cells were centrifuged at 4500 rpm for 5 min and re-suspended in dye solution (optimized concentrations of the Live/Dead Cell Double Staining Kit of Sigma-Aldrich). Single stained cells were also prepared for fluorescence compensation in the flow cytometer. The plate was incubated at 37°C for 15 min ([@B59]). After the incubation period, the cells were centrifuged (4500 rpm for 5 min) and resuspended in 100 μL PBS. Data were then acquired using Amnis^TM^ FlowSight (Merck KGaA) imaging flow cytometer equipped with a 488 nm laser. Six thousand (6000) cell events were acquired per replicate, and 87% cell events were analyzed to eliminate cell debris. Propidium iodide fluorescence was measured at 642--745 nm band (Channel 5), and calcein fluorescence was measured at 505--560 nm band (Channel 2). The analysis was done using IDEA.6.2.188. Release.86x application software considering zero rfu as the lowest fluorescence unit. Propidium iodide fluorescing cells (R1) were gated as dead cells with permeant cell membranes, and calcein fluorescing cells (R2) were gated as live cells ([@B86]). The experiment was performed in triplicates.

Chemical Profiling {#S2.SS8}
------------------

### Thin-Layer Chromatography Profiling {#S2.SS8.SSS1}

Thin-layer chromatography (TLC) profile of the most active extract was carried out using pre-coated TLC plates (Merck TLC Silica Gel 60 W F254s--normal phase) and methanol--dichloromethane (1:13) as solvent system through one-way ascending technique. The developed chromatogram was visualized under UV light at 365 and 254 nm and retention factor (R~f~) values of each band were calculated ([@B43]). Direct bioautography of the chromatogram was further performed by covering the surface of the TLC plate with a soft agar (MHA 0.8% agar) seeded with 1 × 10^6^ CFU/mL of *S. aureus* ATCC BAA-44 and incubated overnight. The zone of inhibition of antibacterial components was visualized by detecting mitochondrial reductase enzyme activity of viable cells using a resazurin reduction-based reaction. The metabolically active viable cells convert resazurin (blue colored compound) to its reduced form resorufin (pink colored compound). Thus, the zone of inhibition appears as blue spot over a pink background ([@B20]; [@B19]; [@B45]).

### Chromatographic Purification of Bioactive Compound {#S2.SS8.SSS2}

Guided by UV activity of bioactive bands in TLC-bioautography, the crude extract of the most active actinobacterial isolate was purified through a silica column (0.5 mm diameter × 54 mm height). Dichloromethane (DCM) followed by methanol-dichloromethane (1:13) was used as the mobile phase. Collected fractions were spotted onto a silica TLC plate and developed using methanol-dichloromethane (1:13). The fractions containing bioactive bands based on UV activity were pooled together and dried using a vacuum concentrator (Eppendorf^TM^ Vacufuge^TM^ Concentrator) at V-HV mode, 30°C for 2 h). Subsequently, the dried bioactive fraction was developed on a silica TLC plate using methanol-dichloromethane (1:13) as solvent. The identified bioactive bands based on R~f~ values in the TLC profile were isolated by preparative-TLC method using methanol-dichloromethane (1:13) solvent system.

### LCMS Analyses of Bioactive Fraction {#S2.SS8.SSS3}

Mass spectrum for dereplication analysis were acquired using high-resolution mass spectrometer (Waters Xevo^®^ G2-XS QTOF) equipped with high-performance system, StepWave^TM^ ion source technology, XS collision cell technology, QuanTOF^TM^ technology, UPLC/TOFMR for high transmission mode, and UPLC/MS^e^ for data acquisition. The solvent system was water with 0.1% (v/v) formic acid (solvent A) and acetonitrile with 0.1% (v/v) formic acid (solvent B). The analysis was performed with flow rate of 0.5 mL/min with an oven temperature at 40°C. The interface used for MS^e^ was electron spray ionization (ESI) with a collision energy of 6.0 eV for low energy and 10.0 eV for high energy. The scan time was set to 0.250 s using polarity positive mode with a mass range scan of m/z 50--900, and using a single UV wavelength of 254 nm. MS data were analyzed using Waters UNIFI Scientific Information System^®^ and Chemspider^TM^ Database.

Results and Discussion {#S3}
======================

Members of the phylum Actinobacteria, which is exemplified by the genus *Streptomyces*, are well-known to produce bioactive compounds with various biological and pharmaceutical importance. Most of these compounds were isolated from terrestrial sources ([@B9]; [@B82]). However, there were reports recently, where their marine counterparts were also recognized as a source of bioactive compounds ([@B69]; [@B87]; [@B33]; [@B50]; [@B75]). The condition in the marine environment is remarkably different from that of the terrestrial environment. It is a hostile niche ([@B6]; [@B42]; [@B81]), where marine microorganisms are exposed to low nutrition, high salinity, and high-pressure ([@B71]; [@B3]). As a result, marine microorganisms developed unique metabolic and physiological ability to survive by activating their environment adaptation genes (ENAs) ([@B3]). Because of this, they produce different secondary metabolites that their terrestrial counterparts do not have ([@B42]; [@B92]; [@B27]).

In the last decade, marine sediments have become reference hotspots for bioprospecting of marine *Streptomyces* with antibiotic activities ([@B48]; [@B88]). Recent reports described that marine sediment-derived *Streptomyces* species are producers of diverse antibiotic compounds. This includes 2-alkyl-4-hydroxyquinoline antibiotics and antifungals produced by *Streptomyces* sp. strain MBTG13 isolated from sediments of Jeju Island, South Korea ([@B52]), polycyclic polyether compounds, terrosamycins A and B, produced by *Streptomyces* sp. RKND004 isolated from sediments of Prince Edward Island, Canada ([@B72]), and oxazole-triene compound, inthomycin B, produced by *Streptomyces* sp. YB104 isolated from deep sediments in South Atlantic Ocean ([@B85]). These reports imply that *Streptomyces* thriving in underexplored niches such as marine sediments are resource for potential antibacterial compounds that are of diverse chemical characteristics.

As part of our natural drug discovery program for new antibiotics, we recovered 35 actinobacterial isolates from marine sediment samples collected near Romblon islands, Philippines using a culture-dependent isolation technique in selective minimal marine media ([@B56]; [@B44]; [@B24]). In this approach, we utilized two media (noble agar and ISP4) with components that mimic the sea water nutrients, pH, and salinity. Further, the media contain cyclohexamide to inhibit fungal contamination and the antibiotic rifamycin to select Actinobacteria ([@B56]; [@B44]; [@B38]; [@B24]; [@B22]; [@B46]; [@B47]; [@B75]).

The morphological characteristics of the actinobacterial isolates were profiled according to their aerial (spores) and substratum (pigmentation) mycelium ([Table 1](#T1){ref-type="table"}). Results showed diverse substratum mycelium production ranging from no pigmentation to yellowish, red-orange to red, and light yellowish-orange to brown. Although recovered from the same collection site, the isolates have varied growth period. Some (4 out of 35 isolates, 11%) grew for as fast as 33 days, while 14% (5 out of 35 isolates) were slow growers that required more than 100 days to develop. In terms of culture-dependent isolation, 29 isolates (82.9%) were recovered using dry stamp method while only six isolates (17.1%) were recovered using heat shock method. Besides, 60% (21 isolates) grew well in the noble agar medium while only 40% (14 isolates) grew well in the ISP4 medium. Our results revealed that the isolates in this study are diverse, as shown by the various diffusible pigments they produced, as well as growth variation in minimal marine media.

###### 

Isolation profile of marine sediment-derived actinobacterial strains.

  **Code**   **Collection site**   **Method of isolation**   **Incubation Period (days)**   **Medium for isolation and description of colonies**                                  
  ---------- --------------------- ------------------------- ------------------------------ ------------------------------------------------------ ------------------------------ --------------------
  DSD044     Lugbung               DSM                       33                             Noble agar                                             Grayish-white                  Red-orange
  DSD045     Lugbung               DSM                       33                             Noble agar                                             Gray                           Red-orange
  DSD046     Lugbung               DSM                       33                             Noble agar                                             Gray                           Red-orange
  DSD047     Lugbung               DSM                       33                             Noble agar                                             Gray                           None
  DSD048     Lugbung               HSM                       68                             Noble agar                                             Gray                           None
  DSD049     Lugbung               HSM                       68                             Noble agar                                             Grayish-white                  Red
  DSD050     Lugbung               HSM                       68                             Noble agar                                             Gray                           Light yellow-brown
  DSD051     Lugbung               HSM                       68                             Noble agar                                             Gray                           Light yellow-brown
  DSD052     Lugbung               HSM                       68                             Noble agar                                             Gray                           Light yellow-brown
  DSD053     Lugbung               HSM                       68                             Noble agar                                             Gray                           Red
  DSD054     Alad                  DSM                       42                             ISP4                                                   Gray with some white portion   Brown
  DSD055     Lugbung               DSM                       42                             ISP4                                                   Gray                           Yellowish-brown
  DSD056     Lugbung               DSM                       34                             ISP4                                                   Grayish with white portion     Yellowish-brown
  DSD057     Lugbung               DSM                       34                             ISP4                                                   Grayish with white portion     Yellowish-brown
  DSD058     Lugbung               DSM                       43                             ISP4                                                   Grayish with white portion     Yellowish
  DSD059     Lugbung               DSM                       43                             ISP4                                                   Grayish with white portion     Yellowish-brown
  DSD060     Lugbung               DSM                       43                             ISP4                                                   Gray                           Yellowish
  DSD061     Lugbung               DSM                       43                             ISP4                                                   Gray                           Yellowish
  DSD062     Lugbung               DSM                       43                             ISP4                                                   Gray                           Yellowish
  DSD063     Lugbung               DSM                       43                             ISP4                                                   Gray                           Yellowish
  DSD064     Alad                  DSM                       34                             Noble agar                                             Grayish-white                  Yellowish-brown
  DSD065     Alad                  DSM                       34                             Noble agar                                             Gray                           Yellowish-brown
  DSD066     Alad                  DSM                       34                             Noble agar                                             White                          Yellowish
  DSD067     Alad                  DSM                       34                             Noble agar                                             White                          Yellowish-brown
  DSD068     Alad                  DSM                       34                             Noble agar                                             Gray                           None
  DSD069     Lugbung               DSM                       47                             ISP4                                                   Gray                           None
  DSD070     Alad                  DSM                       59                             ISP4                                                   Gray                           Red
  DSD071     Alad                  DSM                       103                            Noble agar                                             White                          Brownish-yellow
  DSD072     Alad                  DSM                       103                            Noble agar                                             White                          Brownish
  DSD073     Alad                  DSM                       103                            Noble agar                                             White                          Brownish
  DSD074     Alad                  DSM                       67                             ISP4                                                   Gray                           Red
  DSD075     Alad                  DSM                       67                             ISP4                                                   Gray                           Red
  DSD076     Alad                  DSM                       103                            Noble agar                                             White                          Brownish
  DSD077     Alad                  DSM                       103                            Noble agar                                             White                          Brownish
  DSD078     Alad                  DSM                       67                             Noble agar                                             Grayish white                  Red

DSM, dry stamp method; HSM, heat shock method.

Antibacterial Activity Screening of Crude Extracts {#S3.SS1}
--------------------------------------------------

The crude extracts of actinobacterial isolates ([Supplementary Figure 1](#SM1){ref-type="supplementary-material"}) were initially screened for antibacterial activity through agar well diffusion assay against *S. aureus* ATCC BAA-44. The results demonstrated that out of 35 crude extracts, seven (20%) showed antibacterial activity against *S. aureus* ATCC BAA-44 that exhibited zones of inhibition ranging from 4.1--15.0 mm ([Table 2](#T2){ref-type="table"}). Isolate DSD069 exhibited the highest zone of inhibition of 15.0 mm (±0.2 SD) at 2.0 mg/well, which is nearly equal to the activity of tetracycline at 14.0 mm (±0.1 SD) at 0.05 mg/well.

###### 

Agar well diffusion assay against multidrug-resistant *S. aureus*

  **Treatments**   **Zone of Inhibition (mm)**
  ---------------- -----------------------------
  Tetracycline     14.0 ± 0.1
  DSD047           4.1 ± 0.2
  DSD061           8.0 ± 2.0
  DSD062           5.9 ± 0.1
  DSD065           5.8 ± 0.7
  DSD067           4.3 ± 0.5
  DSD069           15.0 ± 0.2
  DSD070           4.8 ± 0.4

Data presented are mean zone of inhibition (mm) ± SD (standard deviation) of the bioactive marine sediment-derived actinobacterial isolates against

S. aureus

ATCC BAA-44 (1 × 10

6

CFU/mL) through agar well diffusion assay. Cultures of the test bacterial strains in Mueller-Hinton agar plates were exposed to treatments namely,

Actinobacterial

crude extract (2 mg/well), tetracycline - positive control (0.05 mg/well) and DMSO (negative control) for 18--24 h. The experiment was performed in three trials.

The results obtained from well-diffusion assay were further validated by microbroth susceptibility assay. Out of the seven crude extracts found active in well-diffusion assay, six extracts showed more than 50% growth inhibition ([Figure 1](#F1){ref-type="fig"}) in microbroth susceptibility assay as confirmatory screening. Isolate DSD069 crude extract was found to show higher growth inhibition of 96.40% at 2.5 mg/mL against *S. aureus* ATCC BAA-44 in comparison to tetracycline that showed 95.48% at 0.25 mg/mL. Isolate DSD069 was selected for subsequent tests not only for its confirmatory high antibacterial activity against *S. aureus* ATCC BAA-44 but also for its broad antibacterial activities against eight target bacteria ([Supplementary Table 1](#SM1){ref-type="supplementary-material"}). Investigation of the antibacterial compounds against these target bacteria is ongoing and will be reported in due course.

![Antibacterial activity of bioactive actinobacterial isolates against multidrug-resistant *Staphylococcus aureus*. Data illustrated are the percent growth inhibition (± SD) of the antibacterial isolates against *S. aureus* ATCC BAA-44 evaluated through microbroth susceptibility assay. Cultures of test bacterial strain (1 × 10^6^ CFU/mL) were exposed to different actinobacterial extracts (2.5 mg/mL), positive control tetracycline (0.25 mg/mL), and DMSO (negative control) for 24 h. The percent growth inhibition were determined at 620 nm using the microtiter plate reader. The experiment was done in triplicates and performed in three trials.](fmicb-11-00743-g001){#F1}

16S rRNA Gene Sequence of Isolate DSD069 {#S3.SS2}
----------------------------------------

The identity of isolate DSD069 was determined using its 16S rRNA gene sequence. Using BLAST, the nearly complete 16S rRNA gene sequence (1411 bp) revealed 99.93% gene homology with *Streptomyces griseorubens* strain NBRC 12780, which was corroborated with the results obtained in phylogenetic analysis using Molecular Evolutionary Genetics Analysis (MEGA, V7) ([Supplementary Figure 2](#SM1){ref-type="supplementary-material"}). This result indicates that isolate DSD069 is a marine-derived *Streptomyces griseorubens* strain. The nearly complete 16S rRNA gene sequence was deposited in the GenBank with accession number [MN818600](MN818600). *S. griseorubens* strain DSD069 produced gray spores and no diffusible pigment when grown in marine ISP4 medium. SEM analysis of the spores revealed globular shape with size ranging from 1 to 2 μm ([Figure 2](#F2){ref-type="fig"}).

![Scanning electron photomicrograph of marine sediment-derived *Streptomyces griseorubens* strain DSD069. **(A)** Photomicrograph of spores at 9,500x magnification, and **(B)** photomicrograph of spore at 25,000x magnification.](fmicb-11-00743-g002){#F2}

*Streptomyces griseorubens* is a soil-derived actinobacterium ([@B64]) that is involved in carbon and nitrogen recycling ([@B35]). Further, *S. griseorubens* possesses antibacterial activity against *Pseudomonas aeruginosa, S. aureus, Escherichia coli, S. pneumoniae*, and *Bacillus subtilis* ([@B1]). A recent report described two lipocyclopeptide antibiotic compounds produced via non-ribosomal polypeptide synthetase (NRPS) biosynthetic gene cluster (BGC) in *Streptomyces griseorubens* strain INA 00887 ([@B80]). These antibiotics, namely, cryst-1 (Aspartocin B and C) and cryst-2 (Aspartocin A), are two major components of crystallomycin complex, an antibiotic discovered 60 years ago when advanced analytical tools were not available to fully characterize the compounds ([@B80]). Although *S. griseorubens* is known to be terrestrial, a *S. griseorubens* strain was previously isolated from marine sediments collected from the seabed in Weihai, China ([@B90]). Interestingly, the strain required seawater for growth and biosynthesis of anticancer metabolites, indicating that the strain has evolved and developed genes for marine adaptation (i.e., marine adaptation genes, MAG) as a mechanism to adapt in marine environment ([@B90]). The same adaptive mechanism may possibly have contributed to the survival of *S. griseorubens* strain DSD069 in the marine environment, thus allowing to produce antibiotic metabolites.

Antibacterial Activity Profile of *Streptomyces griseorubens* Strain DSD069 {#S3.SS3}
---------------------------------------------------------------------------

Our results in the time-kill kinetics assay of the *S. griseorubens* strain DSD069 crude extract at 2.5 mg/mL against *S. aureus* ATCC BAA-44 showed a time-dependent antibacterial action, with a similar killing trend with that of tetracycline (0.25 mg/mL, positive control) ([Figure 3](#F3){ref-type="fig"}). The crude extract (2.5 mg/mL) exhibited minimal antibacterial activity (58.11%) after 6 h incubation time then gradually increased (89.59%) after 12 h and reached maximum inhibition (96.44%) after 24 h incubation period.

![Time-kill kinetics against multidrug-resistant *S. aureus* ATCC BAA-44. Data presented are the % growth inhibition (± SD) of the treatments at different time points. *S. aureus* ATCC BAA-44 (1 × 10^6^ CFU/mL) was exposed to *S. griseorubens* strain DSD069 (2.5 mg/mL), 0.25 mg/mL tetracycline (positive control), and DMSO (negative control) for 24 h. Bacterial cell density was measured and corresponding % growth inhibition was calculated every 6 h interval from time 0 until 24 h incubation. The experiment was done in triplicates and performed in three trials.](fmicb-11-00743-g003){#F3}

When tested by microbroth dilution assay to determine its minimum inhibitory concentration (MIC), the crude extract showed 2.44 μg/mL MIC value in comparison to tetracycline with MIC value of 31.25 μg/mL. These results suggest that at a lower concentration the crude extract exhibits strong antibacterial activity that is attributable to either a single antibacterial compound present in the crude extract or several compounds working synergistically to elicit a strong antibacterial action ([@B84]; [@B89]).

### Cell Membrane Disruption Assay {#S3.SS3.SSS1}

Bacterial cell membrane integrity was investigated through a leakage assay by measuring the leaked DNA and proteins. Results showed that the antibacterial activity is associated with membrane damage in a concentration-dependent manner ([Figure 4](#F4){ref-type="fig"}). High absorbance values at 260 and 280 nm suggest leakage of DNA and proteins, respectively, which suggest that bacterial cell membrane integrity may have been compromised, allowing the intracellular materials (DNA and proteins) to leaked out of the cell. The percent of DNA and protein leakage of *S. griseorubens* strain DSD069 crude extract was calculated relative to 5% Tween 80, a known compound that affects cell membrane permeability (positive control) ([@B17]). The result showed that *S. griseorubens* strain DSD069 crude extract exhibited 85.27% DNA leakage and 67.68% protein leakage at 2.5 mg/mL concentration.

![Compromised cell membrane permeability and integrity. Data illustrated are **(A)** percent leakage of the UV~260~ (DNA) and UV~280~ (proteins) absorbing intracellular materials, and **(B)** TEM analysis of *S. aureus* ATCC BAA-44 exposed to different treatments namely, Untreated cells of *S. aureus* ATCC BAA-44 as a control, DMSO as a negative control, and *S. griseorubens* strain DSD069 crude extract (2.5 mg/mL).](fmicb-11-00743-g004){#F4}

This observation was further validated by TEM analysis. It was found that *S. aureus* ATCC BAA-44 cells exposed to *S. griseorubens* strain DSD069 extract at 2.5 mg/mL for 24 h showed cell membrane disruption ([Figure 4B](#F4){ref-type="fig"}). The cells appeared with an irregular shape, collapsed, translucent, and formed aggregates of shrunken cells. These findings confer the cell membrane damaging effect of *S. griseorubens* strain DSD069 crude extract. While untreated cells and DMSO treated cells appeared to be spherical with smooth cell surface even on dividing cells; hence, indicating that the cell membranes are still intact.

To further assess the damaging effects of *S. griseorubens* strain DSD069 extract on cell membrane permeability and integrity, flow cytometry experiment using fluorescent dyes, calcein AM, and propidium iodide was performed. Calcein emits green fluorescence when intracellular esterases of live cells convert calcein AM to calcein. In contrast, red-fluorescent propidium iodide can only penetrate bacterial cells with compromised cell membrane permeability or integrity. Cell populations in the flow cytometer dot plots were clustered into two regions, namely dead or membrane-damaged cells (R1), which have strong propidium iodide fluorescence, and live cells (R2), which have strong calcein fluorescence ([@B86]). The untreated (99.07%) and DMSO-treated (99.10%) cells were mostly live cells, as indicated by high populations of calcein-fluorescing cells ([Figure 5](#F5){ref-type="fig"}). Ethanol-treated cells, on the other hand, exhibited a high cell population (99.6%) fluorescing with propidium iodide, thus indicating that these cells were dead and have damaged cell membranes. After 4 h of incubation, *S. aureus* ATCC BAA-44 cells treated with *S. griseorubens* strain DSD069 crude extract at 2.5 mg/mL (the same concentration used in protein and DNA leakage assay and time kill assay) exhibited 76.54% of dead cells with damaged cell membrane as indicated by propidium iodide fluorescing cells and only 23.46% of calcein fluorescing cells (live cells). On the contrary, vancomycin at 7.5 mg/mL treatment exhibited only 3.82% of the dead and membrane-permeant cell population, and a large population of live cells fluorescing with calcein (96.18%) was observed. Previous reports on vancomycin time-kill kinetics against methicillin resistant *S. aureus* strains suggest onset antibacterial activity after 4 h incubation period ([@B70]) and more than 90% inhibition after 8 h incubation period ([@B36]). Moreover, this suggests the slow inhibiting action of vancomycin explaining why only a small percentage (3.82%) of the dead cell population was observed in our experiment.

![Cell membrane permeability effect of *Streptomyces griseorubens* strain DSD069 crude extract. Data presented are flow cytometer scatter plots profile of various treatments namely: **(A)** Untreated, **(B)** DMSO, **(C)** 70% Ethanol, **(D)** Vancomycin, 7.5 mg/mL, and **(E)** *Streptomyces griseorubens* strain DSD069 crude extract, 2.5 mg/mL. The experiment was done in triplicates.](fmicb-11-00743-g005){#F5}

Collectively, the results of the assays confirm that the loss of viability of multidrug resistant *S. aureus* ATCC BAA-44 when treated with *S. griseorubens* strain DSD069 crude extract is a consequence of cell membrane damage. The destruction of cell membrane is demonstrated by (a) leakage and loss of vital cell constituents, including DNA and proteins, (b) irregular shrinkage of cells, and (c) enhanced membrane permeability as shown by propidium iodide uptake.

Antibacterial Compounds From *Streptomyces griseorubens* Strain DSD069 {#S3.SS4}
----------------------------------------------------------------------

To identify the compound/s responsible for the antibiotic activity against the multidrug resistant *S. aureus* ATCC BAA-44, thin layer chromatography (TLC) bioautography was performed. The bioautography assay result suggests that bands with R~f~ values of 0.79 and 0.88 possessed antibacterial activity against *S. aureus* ATCC BAA-44 as indicated by the blue coloration in the bioautogram ([Supplementary Figure 3](#SM1){ref-type="supplementary-material"}). The bioactive band at R~f~ 0.79 has a characteristic intense orange fluorescence at 365 nm, while the band at R~f~ 0.88 has a dark orange fluorescence suggesting aromaticity.

Purification of the active components was done by passing 88.6 mg of *S. griseorubens* strain DSD069 crude extract through a silica column using dichloromethane followed by methanol-dichloromethane (1:13) as the mobile phase, which yielded 50 fractions ([Supplementary Figure 4](#SM1){ref-type="supplementary-material"}). The fractions were developed in a silica TLC plate using a methanol-DCM (1:13) solvent system and viewed under UV at 254 and 365 nm. Based on UV activity, fractions 37--42 were pooled together and dried that yielded 12.9 mg. Preparative silica TLC was used to further separate the bioactive bands at R~f~ 0.79 and R~f~ 0.88 and was designated as BAF1 and BAF2, respectively.

BAF1 was obtained as a yellow film. The molecular formula was determined as C~22~H~16~O~6~ by high-resolution electrospray ionization mass spectrometry (HRESIMS) (*m/z* 377.10274 \[M + H\]^+^, calcd. 377.10251), which indicated 15 degrees of unsaturation ([Figure 6](#F6){ref-type="fig"}). MSe and dereplication analysis (Waters UNIFI Scientific Information System^®^ and Chemspider^TM^ database) revealed that BAF1 matched with Bisanhydroaklavinone, 1 ([Supplementary Figure 5](#SM1){ref-type="supplementary-material"}). On the other hand, BAF2 was also obtained as a yellow film. The molecular formula was determined as C~22~H~16~O~7~ by high resolution electrospray ionization mass spectrometry (HRESIMS) (*m/z* 393.09733 \[M + H\]^+^, calcd. 393.09743), which indicated 15 degrees of unsaturation ([Figure 6](#F6){ref-type="fig"}). BAF2 matched with 1-Hydroxybisanhydroaklavinone, **2** ([Supplementary Figure 6](#SM1){ref-type="supplementary-material"}).

![Structures of anthracycline shunt metabolites: Bisanhydroaklavinone **(1)** and 1-Hydroxybisanhydroaklavinone **(2)**.](fmicb-11-00743-g006){#F6}

To investigate its antibacterial activity, microbroth susceptibility assay was performed at 100 mg/mL concentration against *S. aureus* ATCC BAA-44. Our results showed that **1** and **2** exhibited antibacterial activity of 92.09% and 99.14%, respectively. In comparison, tetracycline showed 93.40% inhibition at 50 μg/mL ([Supplementary Figure 7](#SM1){ref-type="supplementary-material"}).

The antibacterial activity against *S. aureus* ATCC BAA-44 was further confirmed by microbroth dilution assay to determined its minimum inhibitory concentration (MIC). Compound **1** strongly inhibits the growth of *S. aureus* ATCC BAA-44 as shown by its minimum inhibitory concentration (MIC) value of 6.25 μg/mL. Compound **2** and tetracycline displayed weak antibacterial activity against *S. aureus* ATCC BAA-44 with MIC value of 50 μg/mL and 50 μg/mL, respectively ([Supplementary Figure 8](#SM1){ref-type="supplementary-material"}).

Anthracycline Shunt Metabolites: Bisanhydroaklavinone (**1**) and 1-Hydroxybisanhydroaklavinone (**2**) {#S3.SS5}
-------------------------------------------------------------------------------------------------------

Compounds **1** and **2** are shunt metabolites of *Streptomyces* anthracycline glycosides such as the aclacinomycins (e.g., aclarubicin) ([@B30]; [@B60]; [@B41]; [@B57]), rhodomycins (e.g., daunorubicin and doxorubicin) ([@B16]; [@B7]; [@B37]), and cinerubins (cinerubin A and cinerubin B) ([@B23]; [@B31]). These anthracycline glycosides, however, are well known anticancer drugs ([@B32]; [@B58]). Most of these bioactive anthracyclines are glycosides, containing one or more sugar moieties attached to the aglycone, which was reported to be an important structural requirement for their anticancer activities ([@B21]).

Compound **1** was previously reported to be a biosynthetic shunt product of block mutant strains of *Streptomyces galilaeus* as part of a study to understand the biosynthesis of aclacinomycins ([@B61]; [@B79]). On the other note, **2** was reported as an isomer of Bisanhydro-δ-rhodomycinone and Bisanhydro-ε-rhodomycinone ([@B15]). Compound **2** is also known as η-pyrromycinone, a non-glycosidic compound isolated from a soil-derived *S. galilaeus* from Isle of Hidensee, Germany together with anticancer cinerubin A ([@B67]). No prior studies on the anticancer and antibiotic activity of **1** and **2** has been reported.

Chemical synthesis revealed that **1** could be derived from aklavinone and **2** from ε-pyrromycinone through hydrobromide/glacial acetic acid reaction and from 7-desoxyaklavinone and ζ-pyrromycinone through Pd/Mohr or Pd/Kohle reaction, respectively ([@B29]). This chemical synthesis work supports the report that **1** and **2** can be double dehydration products of anthracyclinones produced by *Streptomyces* strains ([@B14]). This dehydration process, particularly on ring D of tetracenedione chromophore of these major aglycones, readily takes place in acidic conditions that resulted in the formation of 7,9-diols, which subsequently undergo bis-hydration further resulting to the aromatization of ring D ([@B55]). Compound **2** is hydroxylated at C-1 position of tetracenedione nucleus. This hydroxylation event was in the biosynthesis of anticancer cinerubins where AclR enzyme catalyzes the hydroxylation at C-1 position of aklavinone. The mechanism and reaction pathway of C-1 modification of the aglycone is not fully understood ([@B11]). Interestingly, studies on the biosynthetic gene cluster of a similar anthracycline anticancer derivative, nogalomycin, involved a two-component monooxygenase SnoaW/SnoaL2 enzyme that is responsible for the hydroxylation at C-1 tetracenedione nucleus of aklavinone to 1-hydroxyaklavinone prior to glycosylation to form nogalomycin ([@B10]).

In this study, we found that **1** and **2** are metabolites accumulated in the biomass of marine sediment-derived *S. griseorubens* strain DSD069. Based on this finding, we propose in [Scheme 1](#CS1){ref-type="fig"} that the accumulation of dehydrated, non-glycosylated anthracyclinone compounds **1** and **2** was influenced by the acidity of the growth medium used in this study (pH 5.0--6.0) or perhaps other unknown mechanisms that favors the spontaneous dehydration and subsequent aromatization of ring D in the tetracenedione chromophore. This proposed mechanism is consistent with the previous report on spontaneous dehydration of aklavinone in an acidic environment to form Bisanhydroaklavinone (**1**) ([@B55]). Moreover, perhaps SnoaW/SnoaL2, AclR enzyme (C-1 hydroxylase) or similar functioning enzyme may have been well expressed in marine sediment-derived *S. griseorubens* strain DSD069 that may have favored the formation of 1-Hydroxybisanhydroaklavinone (**2**).

![Putative biosynthetic pathway of 1 and 2 in marine sediment-derived *Streptomyces griseorubens* strain DSD069.](fmicb-11-00743-g007){#CS1}

Conclusion {#S4}
==========

The findings in this study provide evidence on the potential of marine sediment-derived *Streptomyces* strains from Romblon, Philippines as a source of antibiotics against *S. aureus* ATCC BAA-44. Here, we found that *S. griseorubens* strain DSD069 exhibited its highest antibacterial activity by destroying the cell membrane of *S. aureus* ATCC BAA-44 as demonstrated by protein and DNA leakage and loss of vital cell constituents, irregular shrinkage of cells, and increase membrane permeability. We found that anthracycline shunt metabolites **1** and **2** are the major compounds produced by *S. griseorubens* strain DSD069 that are responsible for its antibacterial activity and plausibly causing the membrane damaging activity. The identification of the molecular target of anthracycline shunt metabolites **1** and **2** as well as their toxicity profiles warrants further investigation. Moreover, we have demonstrated that Philippine marine sediment-derived *S. griseorubens* strain DSD069 is a natural bacterial strain that can produce anthracycline shunt metabolites **1** and **2,** with potential as antibiotic leads to combat ABR. These anthracycline shunt metabolites were accumulated during the fermentation process. We proposed that the intermediate aglycone aklavinone in the biosynthesis of anticancer anthracycline derivatives namely doxorubicin, daunorubicin, and cinerubins underwent spontaneous double dehydration to afford **1**, which subsequently converted to **2** via C-1 hydroxylation. These biosynthetic events are driven by mechanisms that are not yet fully understood in this study. Thus, the intriguing biosynthetic machinery found in Philippine marine-sediment derived *S. griseorubens* strain DSD069 that produce these shunt metabolites are interesting areas to look into for future studies.
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